The invention provides novel deazaxanthine and deazahypoxanthine compounds. The compounds may be useful in the therapy of diseases and conditions in which dipeptidylpeptidase-IV (DPP-IV) is implicated.
[EN] METHODS AND COMPOUNDS FOR TREATING DEPRESSION AND OTHER DISORDERS<br/>[FR] PROCEDES ET COMPOSES PERMETTANT DE TRAITER LA DEPRESSION ET D'AUTRES TROUBLES
申请人:NPS PHARMA INC
公开号:WO2000002551A2
公开(公告)日:2000-01-20
The present invention features compounds active at both the serotonin euptake site and the N-methyl-D-aspartate (NMDA) receptor and the use of such compounds for treating different disorders. Compounds having activity at the serotonin reuptake site and the NMDA receptor ('multi-active compounds') can be used to treat different types of disorders such as depression, obsessive-compulsive disorders (OCD), sleep disorders, sexual dysfunction, and eating disorders. Preferably, the multi-active compounds are used to treat depression.